PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-Feb-2020 AI in healthcare sector in rude health finnCap Group
07-Feb-2020 Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Study Sumitomo Dainippon Pharma Co., Ltd
07-Feb-2020 Johnson & Johnson in Healthy Lead as World’s Most Valuable Pharma Brand Brand Finance
07-Feb-2020 Panthera’s clinical trial site in Preston, UK, open for business Panthera
07-Feb-2020 : Immutep activities report - late-stage Phase IIb metastatic breast cancer results ETA, TACTI-002 results ETA Immutep
07-Feb-2020 Original-Research: Formycon AG (von First Berlin Equity Research GmbH) Formycon AG
06-Feb-2020 MEI Pharma Reports Fiscal Second-Quarter 2020 Results and Operational Highlights MEI Pharma, Inc.
06-Feb-2020 Nasdaq Hearings Panel Grants Therapix Biosciences Extension to Regain Compliance With Listing Requirements Therapix Biosciences Ltd.
06-Feb-2020 Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results Alkermes plc
06-Feb-2020 GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours GenScript Biotech Corporation
06-Feb-2020 Foamix Announces Publication of Phase 3 Studies Evaluating FMX103 for the Treatment of Papulopustular Rosacea in Journal of the American Academy of Dermatology Foamix Pharmaceuticals Ltd.
06-Feb-2020 JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer, for Phase 2b clinical formulation and development JanOne
06-Feb-2020 Moleculin Announces $6.0 Million Registered Direct Offering Moleculin Biotech, Inc.
06-Feb-2020 Save on Prescriptions with ValpakRx(TM) Valpak
06-Feb-2020 NeuroSense Therapeutics Receives Orphan Drug Designation for Amyotrophic Lateral Sclerosis (ALS) Drug, and Announces Initiation of Two Clinical Studies in ALS NeuroSense Therapeutics
06-Feb-2020 CosmosID Inc. and Biomeostasis, SAS Announce Strategic Partnership Focused on Standardization of Pre-Clinical Microbiome R&D CosmosID Inc.
06-Feb-2020 Medios AG: Strong growth in 2019 - Annual forecast slightly exceeded Medios AG
05-Feb-2020 Kodiak Sciences Announces Upcoming Presentation of Additional KSI-301 Phase 1b Clinical Study Data at Angiogenesis, Exudation, and Degeneration 2020 Meeting Kodiak Sciences Inc.
05-Feb-2020 Preliminary Data from NIH/NIAID-sponsored Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate Validates Results of Previous Clinical Trials BiondVax Pharmaceuticals Ltd.
05-Feb-2020 Preliminary Data from NIH/NIAID-sponsored Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate Validates Results of Previous Clinical Trials BiondVax Pharmaceuticals Ltd.